Navigation Links
PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
Date:1/10/2011

ANNAPOLIS, Md., Jan. 10, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has strengthened its research and development and program management functions with the addition of several new leadership appointments.  Namely, Ms. Susan Linna has been appointed Vice President of Program Management; Dr. Kevin Connolly has joined the organization as Senior Program Director for rPA-based anthrax vaccines; and Dr. Kimberly Taylor has joined the organization as Senior Program Director for Valortim®.  In addition, Dr. Thomas Fuerst, who joined the Company in April 2010, has been appointed Executive Vice President and Chief Scientific Officer.

"We are delighted to welcome these experienced and accomplished individuals to the PharmAthene leadership team," remarked Eric I. Richman, President and Chief Executive Officer.  "Collectively, Drs. Fuerst, Connolly and Taylor and Ms. Linna bring a wealth of experience in biopharmaceutical and vaccine development, which will optimally position us to expand our capabilities in biodefense and infectious diseases and drive the future growth of the organization."

Mr. Richman continued, "In addition, Dr. Fuerst's leadership and expertise in biodefense and Ms. Linna's extensive program management experience have enabled us to strengthen the scientific leadership of our biodefense programs and streamline our organizational structure to work more effectively with our government partners.  PharmAthene remains committed to improving our national security by developing 21st century medical countermeasures for anthrax and other biochemical threats, and we're very pleased to welcome these exceptional individuals to our team."  

Prior to joining PharmAthene in April 2010, Dr. Fuerst served as Director, Vaccines and Biologics (2004-2007), and Senior Science and Technolog
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
2. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
3. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
4. PharmAthene Announces Pricing of $15 Million Public Offering
5. PharmAthene Announces Proposed Common Stock Offering
6. PharmAthene Announces $3.9 Million Registered Direct Offering
7. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
8. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
9. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
10. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
11. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... In contrast to traditional LED lights where ... Valoya uses proprietary LED technology to incorporate their spectra ... which is critical in low proximity installations. The Valoya ... its lifetime which is up to four times longer ... investment cost was clearly higher when compared to traditional ...
(Date:12/19/2014)... Dec. 18, 2014  Decision Resources Group finds that ... market will grow moderately through 2023 as the aging ... awareness of dental biomaterials all spur procedure volumes. Growth ... China and India ... procedures within reach for a larger proportion of the ...
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... “Never say, ‘I cannot do ... Department of Physics, advises young women pursuing careers ... SPIE Women in Optics 18-month planner ... ask questions.” , In the annual planner, women ... ranging from university professor and laboratory researcher to ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3
... England, October 9 /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stock Exchange: ... on Tuesday 16 October 2007 at 13.00 pm BST ... will be broadcast live on the internet. Jorn ... (Chief,Research & Development Officer) and Dr Tim Tasker, (EVP ...
... Save Time and Money, OAK BROOK, ... The University,HealthSystem Consortium (UHC), an alliance of ... SciQuest, a provider of e-procurement,technology and services ... partnership to provide organizations participating in,UHC,s new ...
... Affairs and Vice President of ... Pharmaceutical Science, SAN ... biopharmaceutical company focused on developing novel,pain management therapies, announced today the ... Russell Kawahata, Ph.D. as,the Vice President of Pharmaceutical Science. Anthony ...
Cached Biology Technology:Evotec AG: R&D Update on 16 October 2007 Live on the Internet 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3NeurogesX Expands Senior Management Team 2NeurogesX Expands Senior Management Team 3
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... many farmers have found that the brutal combination of high ... yields looking less like the good or the bad and ... University plant pathologist is finding in a statewide study, Kansas ... opponent: viruses. "We,re still analyzing samples, but it,s turning ...
... A new genetic study by a team of Cuban ... with wild populations of critically endangered Cuban crocodiles, which ... only in the Cuban Archipelago. , Cuban crocodiles ... captivity and were suspected to hybridize in the wild. ...
... Elsevier, world-leading provider of scientific, technical and medical information ... (ADSA) announce the winners of the first annual ... Papers published in JDS throughout 2008 were eligible and ... were taken into consideration. Awards are being conferred in ...
Cached Biology News:Plant pathologist finding Kansas wheat fields a molecular battleground this season 2Study: Wild Cuban crocodiles hybridize with American crocs 2Elsevier and ADSA announce winners of first annual Journal of Dairy Science Most Cited Awards 2Elsevier and ADSA announce winners of first annual Journal of Dairy Science Most Cited Awards 3
... pCITE-2a-c(+) vectors are designed for enhanced translation of ... e.g. rabbit reticulocyte lysate. The maps for pCITE-2b(+) ... the following exceptions: pCITE-2b(+) is a 3793 bp ... I and Xcm I sites. Subtract 7 bp ...
...
...
...
Biology Products: